SP-0269

N/A

Report date: 2026/05/12 09:09:45

Base Information

Drug NameSP-0269

Drug Alias NameChlamydia trachomatis vaccine (Sanofi)SP-0269

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsChlamydia Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Develop Information

Active CompaniesSanofi

Inactive CompaniesN/A

Active IndicationsChlamydia Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A